Brookwell Limited Portfolio Analysis (2087V)
09 Janvier 2013 - 5:51PM
UK Regulatory
TIDMBKWD
RNS Number : 2087V
Brookwell Limited
09 January 2013
Brookwell Limited
Portfolio analysis at 31 December 2012
Details of the investments held in the D Share portfolio at 31
December 2012 are set out below.
Investee company Number of Current Current Percentage
shares held value value of portfolio
per
share
pence GBP'000
Northern Investors
Company 791,283 293.00 2,319 67.3%
Universe Group 9,150,000 3.50 320 9.3%
Metalrax Group 6,835,040 4.25 291 8.4%
Private & Commercial
Finance Group 4,696,200 5.75 270 7.8%
Squarestone Brasil
(1) 700,000 23.87 167 4.8%
Evocutis 9,779,860 0.70 69 2.0%
Hotel Corporation 722,071 1.30 9 0.3%
Union Medtech 156,250 1.25 2 0.1%
ESV Group 20,000 2.00 0 0.0%
Orchid Developments
(1) 6,565,447 - - 0.0%
----------------------------- ------------ -------- -------- -------------
Total portfolio investments 3,447 100.0%
-------------
Other net assets 469
----------------------------- ------------ -------- --------
Net assets 3,916
----------------------------- ------------ -------- --------
Notes
1 These investments are suspended/delisted.
2 The above table excludes the Company's holdings in Trans
Balkan Investments and in warrants issued by Squarestone Brasil,
both of which are delisted and carried at nil.
For further information please contact:
Brookwell Limited
Tom Lancaster-King Tel: 01481 726 034
Progressive AIM Realisation Limited (Investment manager)
Robert Legget Tel: 020 7566 5550
Deloitte Corporate Finance (Nominated adviser)
James Lewis / Paul Zimmerman Tel: 020 7936 3000
Marshall Securities Limited (Broker)
John Webb Tel: 020 7490 3788
9 January 2013
Website: www.brookwelllimited.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCQKLFBXFFEBBB
Brookwell D (LSE:BKWD)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Brookwell D (LSE:BKWD)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024